Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02723994
Title A Phase 2 Study of Ruxolitinib With Chemotherapy in Children With Acute Lymphoblastic Leukemia
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Incyte Corporation
Indications

acute lymphoblastic leukemia

Therapies

Prednisone

Dexamethasone + Doxorubicin

Leucovorin

Mercaptopurine + Thioguanine

Asparaginase + Cytarabine

Ruxolitinib

Cyclophosphamide + Methotrexate + Pegaspargase + Vincristine Sulfate

Age Groups: adult | child
Covered Countries USA | CAN

Additional content available in CKB BOOST